Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRALA: Ranibizumab and Laser for Proliferative Diabetic Retinopathy
NCT02005432Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Feb 2012
- Primary completion
- Nov 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in proliferative diabetic retinopathy (PDR), sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02005432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02005432.